These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14272637)

  • 1. THE PLACE OF MONOAMINE OXIDASE INHIBITOR IN OCCLUSIVE PERIPHERAL VASCULAR DISEASE.
    CHHETRI MK; GUHA SR
    J Indian Med Assoc; 1965 Feb; 44():172-7. PubMed ID: 14272637
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness and mode of action of nialamide in peripheral, arterial circulatory disorders].
    HUPKA K; THALER H
    Chemotherapia (Basel); 1962; 4():102-11. PubMed ID: 14450094
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of peripheral ischemic disorders with Niamid].
    FABRE J; LINDHEIMER M; MICHEL B
    Chemotherapia (Basel); 1962; 4():78-101. PubMed ID: 13891220
    [No Abstract]   [Full Text] [Related]  

  • 4. [APROPOS OF THE UTILIZATION OF MONOAMINE OXIDASE INHIBITOR IN GENERAL MEDICINE].
    CHAPUY P; MALLURET J; PLAUCHU M
    Lyon Med; 1964 Nov; 212():937-55. PubMed ID: 14226535
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our experience with Niamid in coronary pain and ischemic pain of the lower extremities].
    MORETTI GF; STAEFFEN J
    Chemotherapia (Basel); 1962; 4():119-22. PubMed ID: 14475930
    [No Abstract]   [Full Text] [Related]  

  • 6. [ADJUNCTION OF A MONOAMINE OXIDASE INHIBITOR TO CLASSIC TREATMENTS OF DISEASES OF THE DIGESTIVE TRACT AND NUTRITION DISORDERS].
    PICQ J; CONSIGNY P
    Toulouse Med; 1964 Nov; 65():1159-72. PubMed ID: 14269858
    [No Abstract]   [Full Text] [Related]  

  • 7. [A MONOAMINE OXIDASE INHIBITOR (NIALAMIDE) IN THE TREATMENT OF DELAYED SPEECH IN CHILDREN].
    TLUCHOWSKI W
    Neurol Neurochir Psychiatr Pol; 1964; 14():231-4. PubMed ID: 14214613
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-arterial therapy in occlusive vascular disease.
    BETTS TW
    Br Med J; 1954 Jun; 1(4875):1360-1. PubMed ID: 13160475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and experimental data on the neurohumoral vascular and tissue effects of nialamide in cardiovascular and metabolic diseases].
    KNICK B
    Chemotherapia (Basel); 1962; 4():297-303. PubMed ID: 14457226
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of vascular headaches with nialamide, a monoamine oxidase inhibitor].
    MICHELACCI S; FRANCHI G
    Minerva Med; 1962 May; 53():1521-3. PubMed ID: 14473424
    [No Abstract]   [Full Text] [Related]  

  • 11. [THERAPEUTIC TRIAL OF THE EFFECT OF A MONOAMINE OXIDASE INHIBITOR ON APATHY OF MENTALLY DEFECTIVE CHILDREN].
    DESIGNOLLE L; BRAUNER F
    Ann Paediatr; 1963; 201():SUPPL:50-9. PubMed ID: 14168088
    [No Abstract]   [Full Text] [Related]  

  • 12. Cigarette smoking and occlusive arterial disease of the legs.
    BARNETT AJ; BOAKE WC
    Med J Aust; 1960 Feb; 47(1)():240-2. PubMed ID: 13796898
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of nialamide on endogenously and exogenously elevated blood ammonia levels in patients with liver disease.
    BEAL RW; BLACKBURN CR
    Australas Ann Med; 1962 Feb; 11():19-23. PubMed ID: 13866111
    [No Abstract]   [Full Text] [Related]  

  • 14. [Summer ulcerations in their relations to peripheral circulation disorders].
    KEINING E; WEBER G
    Dermatol Wochenschr; 1957 May; 135(20):498-506. PubMed ID: 13447452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences in the treatment of peripheral vascular diseases with Lipocapsul].
    JOHNE HO
    Med Welt; 1963 Apr; 14():755-8. PubMed ID: 13957845
    [No Abstract]   [Full Text] [Related]  

  • 16. [CLINICAL AND EXPERIMENTAL REASEARCH ON PROLONGED FIBRINOLYTIC THERAPY. 1. ACTIVATION OF FIBRINOLYSIS BY PROLONGED ADMINISTRATION OF A MONOAMINE OXIDASE INHIBITOR].
    DENICOLA P; GIBELLI A; FRANDOLI G
    Hemostase; 1965 Mar; 5():11-20. PubMed ID: 14346509
    [No Abstract]   [Full Text] [Related]  

  • 17. Intra-arterial histamine in the treatment of occlusive peripheral arterial disease.
    DIXON JA; SCOTT WJ; EPSTEIN MA
    Circulation; 1952 May; 5(5):661-9. PubMed ID: 14926050
    [No Abstract]   [Full Text] [Related]  

  • 18. BLOOD PLATELET ADHESIVENESS AND THE PROTECTIVE ACTION OF NIALAMIDE IN ATHEROSCLEROTIC DYSBASIA.
    GIBINSKI K; WALENDOWSKA J; ZAZGORNIK J
    J Atheroscler Res; 1964; 4():461-4. PubMed ID: 14225226
    [No Abstract]   [Full Text] [Related]  

  • 19. [PARENTERAL NIAMID IN LARGE DOSES IN DEPRESSIVE SYNDROMES. (ATTEMPTED CORRELATION OF THE CLINICAL AND BIOLOGICAL ASPECTS)].
    BAREK A; BURGERMEISTER JJ; REY-BELLET J; TISSOT R; DE AJURIAGUERRA J
    Psychiatr Neurol (Basel); 1964; 148():257-70. PubMed ID: 14249620
    [No Abstract]   [Full Text] [Related]  

  • 20. Double blind trial of nialamide in intermittent claudication. Effects on blood cholesterol, fibrinolysis and 5-hydroxytryptamine.
    Tsapogas MJ; Flute PT
    Vasc Dis; 1964 Sep; 1(5):249-51. PubMed ID: 4867905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.